scholarly journals Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes

2012 ◽  
Vol 91 (1) ◽  
pp. 75-78 ◽  
Author(s):  
Osman David Mansoor ◽  
Debra Kristensen ◽  
Andrew Meek ◽  
Simona Zipursky ◽  
Olga Popovaa ◽  
...  
2003 ◽  
Vol 18 (4) ◽  
pp. 250-258
Author(s):  
Steve Bowers

Abstract This study documented and field-tested a simplified version of the Westside Grading Guidelines as published in the Official Rules Handbook by the Northwest Log Rules Advisory Group. A four-step dichotomous key was documented and field-tested to determine merchantable vs. nonmerchantable logs. The study also documented and field-tested an individual seven-step dichotomous log grading key for evaluating second-growth Douglas-fir (Pseudotsuga menziesii), Sitka spruce (Picea sitchensis), western hemlock (Tsuga heterophylla), and grand fir (Abies grandis) as derived from the Rules For Grading Logs section of the Official Rules Handbook. Results were compared with certified scalers employed by Yamhill Log Scaling & Grading Bureau and Columbia River Log Scaling & Grading Bureau. Eighty-four individuals measured the length, scaling diameter, determined merchantability versus nonmerchantability and assigned log grade for 440 logs. Results showed participants in the study correctly measuring log length 99% of time, scaling diameters were recorded correctly at an 89% rate, and merchantability and log grade at 98 and 97%, respectively. West. J. Appl. For. 18(4):250–258.


2020 ◽  
pp. 174701612092006
Author(s):  
V Ranieri ◽  
H Stynes ◽  
E Kennedy

The Confidentiality Advisory Group (CAG) is a specialised body that advises the Health Research Authority (HRA) and the Secretary of State for Health on requests for access to confidential information, in the absence of informed consent from its owners. Its primary role is to oversee the safe use of such information and to counsel the governing bodies mentioned above as to whether such use is appropriate or inappropriate. Researchers who seek access to England or Wales-based confidential data, for medical purposes that are in the interest of the public, are typically required to submit an application to this body. However, it is not always clear to researchers whether requests for access to patient data fit within the remit of the CAG or a Trust’s local information governance team. This commentary will, therefore, explore the role of the CAG and reflect on how best to support researchers with this question.


2021 ◽  
Vol 6 (5) ◽  
pp. e005032
Author(s):  
Karuna Luthra ◽  
Anna Zimmermann Jin ◽  
Prarthana Vasudevan ◽  
Karen Kirk ◽  
Carol Marzetta ◽  
...  

BackgroundPrevious studies identified factors influencing regulatory approval to introduction timelines for individual vaccines. However, introduction and uptake timelines have not been comprehensively assessed across the portfolio of Gavi-supported vaccines.MethodsWe analysed median times between introduction milestones from vaccine licensure to country introduction and uptake across six vaccine-preventable diseases (VPDs), three delivery platforms and 69 Gavi-supported countries. Data were gathered from public, partner and manufacturer records. VPDs and prequalified vaccines analysed included Haemophilus influenzae type b (DTwP-HepB-Hib, pentavalent), pneumococcal disease (pneumococcal conjugate vaccine, PCV), rotavirus diarrhoea (rotavirus vaccine, RVV), cervical cancer (human papillomavirus vaccine, HPV), polio (inactivated polio vaccine, IPV) and meningococcal meningitis (meningococcal group A conjugate vaccine, MenA).ResultsMedian time from first vaccine licensure to first Gavi-supported country introduction across VPDs at a ‘global level’ (Gavi-supported countries) was 5.4 years. Once licensed, MenA vaccines reached first introduction fastest (campaign=0.6 years; routine immunisation (RI)=1.7 years). Most introductions were delayed. Country uptake following first introduction was accelerated for more recently Gavi-supported RI vaccines compared with older ones.ConclusionFactors accelerating timelines across delivery platforms included rapid product prequalifications by WHO, strong initial recommendations by the WHO Strategic Advisory Group of Experts (SAGE) on Immunization, achieving target product profiles on first vaccine licensure within a VPD and completing several VPD milestones at a global level prior to licensure. Milestones required for introduction in Gavi-supported countries should start prior or in parallel to licensure to accelerate uptake of vaccines delivered through diverse delivery platforms.


2009 ◽  
Vol 70 (3) ◽  
pp. 270-273
Author(s):  
Steven E. Wegner ◽  
L. Allen Dobson ◽  
William W. Lawrence ◽  
Eileen Ciesco

Hadmérnök ◽  
2020 ◽  
Vol 15 (2) ◽  
pp. 31-41
Author(s):  
Attila Csóka

“Search and Extraction” is a NATO capability requirement without definition. The study shows the civilian search and rescue team requirements based on the Guidelines of the International Search and Rescue Advisory Group. A new definition is proposed: “Rescue and Extraction”. In the main part of the study the problems of CBRN decontamination of vehicles, equipment and personnel during a Rescue and Extraction task are discussed.


Sign in / Sign up

Export Citation Format

Share Document